Genetic Signatures Limited (ASX:GSS)
Australia · Delayed Price · Currency is AUD 0.0580
-0.0030 (-4.92%)
Aug 11, 2026, 3:53 PM AEST
Genetic Signatures Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 17.19 | 7.47 | 36.25 | 16.35 | 36.9 | 30.12 |
Short-Term Investments | 12.68 | 23.82 | - | - | - | - |
Cash & Short-Term Investments | 29.87 | 31.3 | 36.25 | 16.35 | 36.9 | 30.12 |
Cash Growth | -4.55% | -13.67% | 121.74% | -55.69% | 22.50% | -3.38% |
Accounts Receivable | 1.94 | 2.55 | 3.25 | 3.19 | 3.64 | 4.96 |
Other Receivables | 2.61 | 5.07 | 6.33 | 8.07 | 0.49 | 0.41 |
Receivables | 4.55 | 7.62 | 9.58 | 11.26 | 4.13 | 5.37 |
Inventory | 8.54 | 9.06 | 6.72 | 8.75 | 10.2 | 12.13 |
Total Current Assets | 42.96 | 47.98 | 52.55 | 36.37 | 51.23 | 47.63 |
Property, Plant & Equipment | 6.08 | 6.66 | 8.49 | 7.22 | 6.78 | 6.05 |
Other Intangible Assets | - | - | 6.25 | 5.49 | 1.65 | 0.37 |
Total Assets | 49.04 | 54.63 | 67.29 | 49.08 | 59.65 | 54.05 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 3.63 | 2.38 | 3.07 | 3.77 | 3.42 | 2.76 |
Accrued Expenses | 0.69 | 0.73 | 1.11 | 1.27 | 1.11 | 0.94 |
Current Portion of Leases | 0.47 | 0.44 | 0.39 | - | 0.03 | 0.33 |
Other Current Liabilities | - | 0.55 | 0.67 | 1.03 | 0.25 | 0.6 |
Total Current Liabilities | 4.78 | 4.1 | 5.23 | 6.07 | 4.81 | 4.62 |
Long-Term Leases | 0.09 | 0.35 | 0.83 | - | 0 | 0.07 |
Pension & Post-Retirement Benefits | 0.07 | 0.09 | 0.12 | 0.1 | 0.05 | 0.02 |
Total Liabilities | 4.95 | 4.54 | 6.18 | 6.16 | 4.85 | 4.71 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 127.65 | 127.65 | 119.43 | 84.44 | 84.43 | 84.16 |
Retained Earnings | -93.48 | -87.11 | -67.01 | -49.15 | -35.1 | -38.16 |
Comprehensive Income & Other | 9.92 | 9.56 | 8.68 | 7.62 | 5.47 | 3.33 |
Shareholders' Equity | 44.09 | 50.09 | 61.1 | 42.91 | 54.8 | 49.34 |
Total Liabilities & Equity | 49.04 | 54.63 | 67.29 | 49.08 | 59.65 | 54.05 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 0.56 | 0.79 | 1.22 | - | 0.03 | 0.4 |
Net Cash (Debt) | 29.31 | 30.5 | 35.03 | 16.35 | 36.86 | 29.72 |
Net Cash Growth | -3.91% | -12.92% | 114.27% | -55.65% | 24.03% | -2.34% |
Net Cash Per Share | 0.13 | 0.13 | 0.21 | 0.11 | 0.25 | 0.20 |
Filing Date Shares Outstanding | 227.14 | 227.14 | 215.27 | 143.41 | 143.39 | 142.91 |
Total Common Shares Outstanding | 227.14 | 227.14 | 215.27 | 143.41 | 143.39 | 142.91 |
Working Capital | 38.18 | 43.88 | 47.32 | 30.3 | 46.43 | 43 |
Book Value Per Share | 0.19 | 0.22 | 0.28 | 0.30 | 0.38 | 0.35 |
Tangible Book Value | 44.09 | 50.09 | 54.86 | 37.43 | 53.16 | 48.97 |
Tangible Book Value Per Share | 0.19 | 0.22 | 0.25 | 0.26 | 0.37 | 0.34 |
Machinery | - | 14.09 | 14.16 | 12.69 | 10.94 | 9.54 |